Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial-Reference-Cited by-同舟云学术

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Published:2014-01 Issue:1 Volume:15 Page:78-86
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ford Hugo E R,Marshall Andrea,Bridgewater John A,Janowitz Tobias,Coxon Fareeda Y,Wadsley Jonathan,Mansoor Wasat,Fyfe David,Madhusudan Srinivasan,Middleton Gary W,Swinson Daniel,Falk Stephen,Chau Ian,Cunningham David,Kareclas Paula,Cook Natalie,Blazeby Jane M,Dunn Janet A

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Gastric Cancer;Hartgrink;Lancet,2009

3. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone;Kang;J Clin Oncol,2012

4. Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma;Assersohn;Ann Oncol,2004

5. Docetaxel as salvage therapy in advanced gastric cancer: a phase II study of the Gruppa Oncologico Italia Meridionale (G.O.I.M.);Giuliani;Anticancer Res,2003

Cited by 514 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer;ESMO Gastrointestinal Oncology;2024-09

2. Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer;International Journal of Cancer;2024-08-02

3. Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer;PharmacoEconomics;2024-07-26

4. Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy;The Oncologist;2024-07-24

5. Utilising systematic reviews to assess potential overtreatment and claim for better evidence-based research: an analysis of anticancer drugs versus supportive care in advanced esophageal cancer;Systematic Reviews;2024-07-18